In addition, we detected increased tumor-infiltrating CD8+ T cells and enhanced CD8+ T-cell effector function as assessed by Granzyme B and IFN-γ expression in tumor-infiltrating CD8+ T cells from the ML323-treated group (Fig. 7c; Supplementary Fig. 6d, e). Here, CD8A is linked to neoplasm.